CONSTANCE DEFREEST: Open Payments
NPI 1154550127 · WAPPINGERS FALLS, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,229 in 110 payments from 13 companies in 2025. Trend: 2023 $1,935 · 2024 $2,203 · 2025 $2,229
Food & beverage: $2,229
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 42 | $667 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 13 | $319 |
| Axsome Therapeutics, Inc. | 10 | $288 |
| Alkermes, Inc. | 13 | $266 |
| Otsuka America Pharmaceutical, Inc. | 9 | $255 |
| Lundbeck LLC | 4 | $81 |
| Janssen Pharmaceuticals, Inc | 5 | $78 |
| Vanda Pharmaceuticals Inc. | 3 | $74 |
| Neurocrine BioSciences, Inc. | 4 | $72 |
| Corium, LLC | 3 | $55 |
Products named: VRAYLAR, REXULTI, CAPLYTA, Auvelity, LYBALVI, FANAPT, INGREZZA, INVEGA SUSTENNA.
Industry payments across NY — which companies pay providers there.
